Clinical Trials Arena on MSN

AiCuris reports positive Phase III pritelivir results for HSV patients

The trial enrolled and treated 101 immunocompromised patients with refractory or resistant HSV infection.
TMCnet

Aicuris Presents Positive Phase 3 Data for Pritelivir in Immunocompromised Patients with Refractory Herpes Simplex Virus at TANDEM

Pritelivir met its primary endpoint of superior lesion healing, achieving a 62.7% lesion healing rate compared to 34.0% with ...
Infectious Disease Advisor

Pritelivir Shows Efficacy for Refractory HSV in Immunocompromised Patients

A phase 3 trial finds pritelivir significantly improves cure rates for immunocompromised individuals with refractory HSV infections.
Hosted on MSN

Herpes IgG Test: Purpose and What Results Mean

The herpes IgG test is a blood test used to diagnose herpes simplex virus (HSV). This includes HSV-1, the type most commonly linked to cold sores, and HSV-2, the type mainly associated with genital ...
Fred Hutch

Exit or not? HSV-1 infection redistributes heterochromatin to exit the nucleus

A recent study In Press at the Journal of Cell Biology reports that herpes simplex virus 1 (HSV-1) exploits heterochromatin to successfully exit the nucleus. The heterochromatin markers macroH2A1 and ...